A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
RasCal Therapeutics, Inc.
RasCal Therapeutics, Inc.
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Continuity Biosciences, LLC
National Institutes of Health Clinical Center (CC)
Kivu Bioscience Inc.
Alterome Therapeutics, Inc.
Boehringer Ingelheim
ViroMissile, Inc.
PanTher Therapeutics
Washington University School of Medicine
National Institutes of Health Clinical Center (CC)
ArriVent BioPharma, Inc.
Amgen
Eli Lilly and Company
Angiex, Inc.
MacroGenics
Revolution Medicines, Inc.
Pheon Therapeutics
Abramson Cancer Center at Penn Medicine
General Oncology, Inc.
Zhejiang University
Eli Lilly and Company
Eli Lilly and Company
Sun Yat-sen University
MOMA Therapeutics
Henry Ford Health System
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Pfizer
Bristol-Myers Squibb
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
AbbVie
M.D. Anderson Cancer Center
Sichuan Baili Pharmaceutical Co., Ltd.
EtiraRx Australia Pty Ltd
UNC Lineberger Comprehensive Cancer Center
Exelixis
Arbele Limited
Minia University
Memgen, Inc.
Revolution Medicines, Inc.
GONGCHU Biotechnology Co., Ltd
Bicara Therapeutics
Senhwa Biosciences, Inc.
Jonsson Comprehensive Cancer Center
University of California, San Diego
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University Hospital, Ghent
University of Rochester